Cargando…
Research Progress on Targeted Antioxidant Therapy and Vitiligo
Vitiligo is a common acquired depigmenting disease characterized by the loss of functional melanocytes and epidermal melanin. Vitiligo has a long treatment cycle and slow results, which is one of the most difficult challenges for skin diseases. Oxidative stress plays an important role as an initiati...
Autores principales: | Zhang, Jingzhan, Hu, Wen, Wang, Peng, Ding, Yuan, Wang, Hongjuan, Kang, Xiaojing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8938057/ https://www.ncbi.nlm.nih.gov/pubmed/35320978 http://dx.doi.org/10.1155/2022/1821780 |
Ejemplares similares
-
Comprehensive Analysis of Cell Population Dynamics and Related Core Genes During Vitiligo Development
por: Zhang, Jingzhan, et al.
Publicado: (2021) -
Protective effects of isorhamnetin against H(2)O(2)-induced oxidative damage in HaCaT cells and comprehensive analysis of key genes
por: Hu, Wen, et al.
Publicado: (2023) -
Identification of key genes and pathways involved in vitiligo development based on integrated analysis
por: Lei, Zixian, et al.
Publicado: (2020) -
The Effect of Transplantation of Cultured Autologous Melanocytes on CXCL9, CXCL10 and CXCL11 Expressions in Vitiligo
por: Xu, Chen, et al.
Publicado: (2023) -
Therapies with Antioxidant Potential in Psoriasis, Vitiligo, and Lichen Planus
por: Guarneri, Fabrizio, et al.
Publicado: (2021)